Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

PRTC

PureTech Health (PRTC)

PureTech Health PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PRTC
DateHeureSourceTitreSymboleSociété
14/01/202113h05Business WirePureTech Founded Entity Vor Announces FDA Clearance of IND Application for VOR33NASDAQ:PRTCPureTech Health PLC
14/01/202112h50Business WireFollica Adds Two Leaders in Aesthetic Medicine and Dermatology to Its Board of DirectorsNASDAQ:PRTCPureTech Health PLC
14/01/202112h50Business WirePureTech Founded Entity Follica Adds Two Leaders in Aesthetic Medicine and Dermatology to its Board of DirectorsNASDAQ:PRTCPureTech Health PLC
12/01/202112h50Business WirePureTech Founded Entity Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.NASDAQ:PRTCPureTech Health PLC
12/01/202112h50Business WireVedanta Biosciences Announces $25 Million Investment from Pfizer Inc.NASDAQ:PRTCPureTech Health PLC
05/01/202108h00Business WirePureTech Announces the Appointment of George Farmer, Ph.D., as Chief Financial OfficerNASDAQ:PRTCPureTech Health PLC
21/12/202013h00Business WirePureTech to Present at 38th Annual J.P. Morgan Healthcare Conference and Other ConferencesNASDAQ:PRTCPureTech Health PLC
11/12/202013h00Business WirePureTech Advances Wholly Owned Candidate LYT-200 into Phase 1 Trial for Potential Treatment of Metastatic Solid TumorsNASDAQ:PRTCPureTech Health PLC
10/12/202013h00Business WirePureTech Initiates Phase 2a trial of LYT-100 (Deupirfenidone) in LymphedemaNASDAQ:PRTCPureTech Health PLC
09/12/202019h42Business WireFollica Announces Pilot Study for Female Pattern Hair Loss Published in International Journal of Women’s DermatologyNASDAQ:PRTCPureTech Health PLC
09/12/202013h00Business WirePureTech Founded Entity Follica Announces Pilot Study for Female Pattern Hair Loss Published in International Journal of Wome...NASDAQ:PRTCPureTech Health PLC
03/12/202013h00Business WirePureTech Initiates Phase 2 trial of LYT-100 (Deupirfenidone) in Long COVID Respiratory Complications and Related SequelaeNASDAQ:PRTCPureTech Health PLC
30/11/202013h00Business WirePureTech to Host Virtual R&D Day for Investors on December 11, 2020NASDAQ:PRTCPureTech Health PLC
24/11/202013h00Business WireVedanta Biosciences Appoints Troy Ignelzi, Chief Financial Officer at Karuna Therapeutics, to Its Board of DirectorsNASDAQ:PRTCPureTech Health PLC
24/11/202013h00Business WirePureTech Founded Entity Vedanta Biosciences Appoints Troy Ignelzi, Chief Financial Officer at Karuna Therapeutics, to its Boa...NASDAQ:PRTCPureTech Health PLC
18/11/202008h00Business WirePureTech’s LYT-100 (Deupirfenidone) Demonstrates Tolerability & Pharmacokinetic Proof-of-Concept in Phase 1 Multiple Ascend...NASDAQ:PRTCPureTech Health PLC
 Showing the most relevant articles for your search:NASDAQ:PRTC

Dernières Valeurs Consultées